PHE-575

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePHE-575
Drug Alias Nametransient receptor potential vanilloid 1 antagonists (PharmEste)second generation TRPV 1 antagonists (PharmEste)PHE-575
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVanilloid receptor antagonists
TargetsTransient receptor potential cation channel subfamily V member 1
Therapy Area/IndicationsUrinary Bladder, OveractiveNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmEste Srl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmEste Srl
Active IndicationsN/A
Inactive IndicationsUrinary Bladder, OveractiveNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A